top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

BIOTECH

London Biotechnology Show 2026 Connects Industry Buyers, Suppliers, Innovators

The London Biotechnology Show 2026 concluded at ExCeL
London after two days of industry engagement.

 Featured Articles. 

7-format11240.jpg
HEALTH

Intuitive surpasses 10,000 robotic-assisted bronchoscopy procedures across Europe with Ion system

7-format11240.jpg
BIOTECH

Big Picture Bio launches with £2.2m to develop AI-designed cancer combination therapies

7-format11240.jpg
BIOTECH

Houdini Bio: tackling the gene-silencing barrier in genetic medicines

7-format11240.jpg
BIOTECH

T-Cypher Bio expands into purpose-built laboratory space at Abingdon Science Park

7-format11240.jpg
HEALTH

The Eye's Hidden Drain, Discovered

7-format11240.jpg
BIOPROCESSING

Bio-Rad Expands Foresight Pro Chromatography Columns for Biomanufacturing

7-format11240.jpg
BIOTECH

£30m venture philanthropy fund launched to accelerate development of new myeloma treatments

7-format11240.jpg
EVENTS

BIX 2026 to explore the future of obesity treatments as full conference agenda is unveiled

7-format11240.jpg
PHARMA

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

 Latest News. 

22nd November, 2026

01.

Incyte’s Zynyz receives MHRA approval and NICE recommendation for anal cancer

Regulatory approval and NICE guidance introduce a new first-line treatment option for eligible patients with advanced squamous cell carcinoma of the anal canal.

19th November, 2026

02.

London Biotechnology Show 2026 Connects Industry Buyers, Suppliers, Innovators

The London Biotechnology Show 2026 concluded at ExCeL

London after two days of industry engagement.

12th November, 2026

03.

Mogrify reports preclinical evidence of retinal regeneration using in vivo cell reprogramming

Mogrify has generated preclinical evidence that its in vivo cell reprogramming technology can preserve and restore visual function in a model of retinal degeneration.

11th November, 2026

04.

PlaqueTec’s BIOPATTERN trial reaches 100 patients as NHS network expands to eight cardiac centres

Cambridge-based PlaqueTec has recruited its 100th participant into a clinical trial investigating the biology of coronary artery disease and potential new approaches to more personalised treatment. The trial has expanded to eight NHS cardiac centres across England.

Editor's Selects.

AI in Science Writing and the Imitation of Understanding

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

Our Partners.

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page